Sea Lane Biotechnologies Unveils a Potential New Class of Biotherapeutics  
7/29/2008 11:18:57 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Sea Lane Biotechnologies, LLC (Sea Lane) today announced the first demonstration of a new class of biotherapeutic molecules called Surrobodies™ with the potential to impart transformative new abilities and benefits into next generation biologic treatments.